Catalyst Wire Dossier Catalyst Wire Dossier

Theolong Tablet 200 mg Twice Daily

theophylline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Theolong Tablet 200 mg Twice Daily, covering 2011-01-24 to 2011-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients [Phase 3]

See pricing